Stroke and MI in Users of Estrogen/Progestogen
NCT00005466 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-18
Summary
To estimate the relative risks of acute myocardial infarction (MI) and of stroke in postmenopausal users of estrogen/progestogen (E/P) combinations and to estimate the relative risks of MI and of stroke in users of estrogen alone.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Coronary Disease
- Cerebrovascular Accident
- Myocardial Infarction
- Postmenopause
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1991-08-31
- Completion
- 1995-07-31
More Related Trials
-
Hormone Replacement Therapy and Prothrombotic Variants
NCT00049933 ·Status: COMPLETED
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy Effects on CVD Risk Factors
NCT00006313 ·Status: COMPLETED
-
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
NCT00565916 ·Status: TERMINATED ·Phase: NA
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
NCT05647876 ·Status: RECRUITING
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Estrogen Deficiency on Cardiovascular Risk
NCT06369363 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226 ·Status: COMPLETED ·Phase: NA
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
NCT05985447 ·Status: RECRUITING
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women
NCT01048606 ·Status: COMPLETED ·Phase: PHASE4
-
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
NCT05057546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Estrogen Diastolic Heart Failure
NCT02693002 ·Status: TERMINATED ·Phase: PHASE4